Results
Myriad Genetics Inc.
06/23/2026 | Press release | Distributed by Public on 06/23/2026 06:32
Management Change/Compensation (Form 8-K)
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On June 17, 2026, Daniel M. Skovronsky M.D., Ph.D., a member of the Board of Directors of Myriad Genetics, Inc. (the "Company") notified the Company that he is resigning as a director, effective immediately. Dr. Skovronsky's resignation was not a result of any disagreement with the Company or due to any matter relating to the Company's operations, policies, or practices.
Myriad Genetics Inc. published this content on June 23, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 23, 2026 at 12:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]